FDA’s Decentralized Trial Guidance: Investigator, Health Care Provider Demarcation Raises Questions

 
• By Brenda Sandburg
Clinical trial
FDA guidance on decentralized clinical trials focuses on the role of local healthcare providers. • Source: Shutterstock

More from Clinical Trials

More from R&D